Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
LSBio offers antibodies, proteins, and cDNAs specific to coronavirus proteins and host proteins involved in coronavirus disease progression. Reagents for investigating SARS-CoV-2, SARS-CoV, MERS, and HCoV coronavirus structural and non-structural proteins, as well as coronavirus-interacting host proteins such as ACE2, TMPRSS2, Cathepsin, and ADAM17 are available and approved for use in multiple applications. We have a wide selection of related recombinant proteins, native proteins, and over-expression lysates. Furthermore, we provide expression-ready ORF cDNA clones to coronavirus genes of prominent research interest.
LSBio offers over 150 antibodies to structural and non-structural coronavirus proteins, including antibodies for the detection of the spike (S), nucleocapsid (N), and envelope (E) proteins of both SARS-CoV and SARS-CoV-2. We also offer antibodies which detect human proteins known to interact with coronaviruses or to contribute to COVID-19 disease progression. Many of our antibodies are available in multiple conjugated forms and are designed for use in a range of assays including ELISA, IHC, Western Blot, IF, and Flow Cytometry.
View LSBio’s library of high-quality recombinant coronavirus proteins, produced in a variety of expression systems and ready for use in functional assays, high throughput screens, structural analysis studies, and a variety of other applications. Full length recombinant proteins to SARS-CoV-2 structural proteins are available for your COVID-19 research needs.
LSBio offers expression-ready ORF clones to a range of coronavirus genes intended for immediate transfection. SARS-CoV-2 clones are available for stable or transient mammalian and lentiviral expression.